An arrhythmogenic metabolite in atrial fibrillation

被引：3

作者：

Krause, Julia ^{[1
,2
]}

Nickel, Alexander ^{[3
]}

Madsen, Alexandra ^{[2
,4
]}

Aitken-Buck, Hamish M. ^{[5
]}

Stoter, A. M. Stella ^{[2
,4
]}

Schrapers, Jessica ^{[2
,4
]}

Ojeda, Francisco ^{[6
]}

Geiger, Kira ^{[3
]}

Kern, Melanie ^{[3
]}

Kohlhaas, Michael ^{[3
]}

Bertero, Edoardo ^{[3
]}

Hofmockel, Patrick ^{[3
]}

Huebner, Florian ^{[7
]}

Assum, Ines ^{[8
,9
]}

Heinig, Matthias ^{[8
,9
]}

Mueller, Christian ^{[2
,6
]}

Hansen, Arne ^{[2
,4
]}

Krause, Tobias ^{[2
,4
]}

Park, Deung-Dae ^{[10
]}

Just, Steffen ^{[10
]}

Aissi, Dylan ^{[6
]}

Boernigen, Daniela ^{[6
]}

Lindner, Diana ^{[2
,6
,22
]}

Friedrich, Nele ^{[11
,12
]}

Alhussini, Khaled ^{[13
]}

Bening, Constanze ^{[13
]}

Schnabel, Renate B. ^{[2
,6
]}

Karakas, Mahir ^{[2
,14
]}

Iacoviello, Licia ^{[15
,16
]}

Salomaa, Veikko ^{[17
]}

Linneberg, Allan ^{[18
,19
]}

Tunstall-Pedoe, Hugh ^{[20
]}

Kuulasmaa, Kari ^{[17
]}

Kirchhof, Paulus ^{[2
,6
,21
]}

Blankenberg, Stefan ^{[2
,6
]}

Christ, Torsten ^{[2
,4
]}

Eschenhagen, Thomas ^{[2
,4
]}

Lamberts, Regis R. ^{[5
]}

Maack, Christoph ^{[3
]}

Stenzig, Justus ^{[2
,4
]}

Zeller, Tanja ^{[1
,2
]}

机构：

[1] Univ Med Ctr Hamburg Eppendorf, Univ Ctr Cardiovasc Sci, Univ Heart & Vasc Ctr Hamburg, Dept Cardiol, Martinistr 52, D-20246 Hamburg, Germany

[2] DZHK German Ctr Cardiovasc Res, Partner Site Hamburg Kiel Lubeck, Hamburg, Germany

[3] Univ Clin Wurzburg, Comprehens Heart Failure Ctr, Wurzburg, Germany

[4] Univ Med Ctr Hamburg Eppendorf, Inst Expt Pharmacol & Toxicol, Hamburg, Germany

[5] Univ Otago, Sch Biomed Sci, Dept Physiol, HeartOtago, Dunedin, New Zealand

[6] Univ Heart & Vasc Ctr Hamburg, Dept Cardiol, Hamburg, Germany

[7] Univ Munster, Inst Food Chem, Munster, Germany

[8] Helmholtz Zentrum Munchen, Inst Computat Biol, Munich, Germany

[9] Tech Univ Munich, Dept Informat, Munich, Germany

[10] Univ Ulm, Dept Internal Med 2, Mol Cardiol, Ulm, Germany

[11] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany

[12] DZHK German Ctr Cardiovasc Res, Partner Site Greifswald, Greifswald, Germany

[13] Univ Clin Wurzburg, Dept Thorac & Cardiovasc Surg, Wurzburg, Germany

[14] Univ Med Ctr Hamburg Eppendorf, Dept Intens Care Med, Hamburg, Germany

[15] IRCCS Neuromed, Dept Epidemiol & Prevent, Pozzilli, Italy

[16] Univ Insubria, Res Ctr Epidemiol & Prevent Med EPIMED, Dept Med & Surg, Varese, Italy

[17] Finnish Inst Hlth & Welf, Helsinki, Finland

[18] Bispebjerg & Frederiksberg Hosp, Ctr Clin Res & Prevent, Capital Reg Denmark, Copenhagen, Denmark

[19] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark

[20] Univ Dundee, Inst Cardiovasc Res, Cardiovasc Epidemiol Unit, Dundee, Scotland

[21] Univ Birmingham, Inst Cardiovasc Sci, Birmingham, England

[22] Univ Freiburg, Univ Heart Ctr Freiburg Bad Krozingen, Dept Cardiol & Angiol, Fac Med,Med Ctr, D-79106 Freiburg, Germany

来源：

JOURNAL OF TRANSLATIONAL MEDICINE | 2023年 / 21卷 / 01期

基金：

欧洲研究理事会;

关键词：

Metabolites; Acyl-carnitine; Atrial fibrillation; Translational medicine; Engineered heart tissue; LONG-CHAIN ACYLCARNITINES; FATTY-ACID OXIDATION; HEART; MITOCHONDRIAL; CALCIUM; CARDIOMYOCYTES; MYOCARDIUM; TISSUE; LEAK;

D O I：

10.1186/s12967-023-04420-z

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Background Long-chain acyl-carnitines (ACs) are potential arrhythmogenic metabolites. Their role in atrial fibrillation (AF) remains incompletely understood. Using a systems medicine approach, we assessed the contribution of C18:1AC to AF by analysing its in vitro effects on cardiac electrophysiology and metabolism, and translated our findings into the human setting.Methods and results Human iPSC-derived engineered heart tissue was exposed to C18:1AC. A biphasic effect on contractile force was observed: short exposure enhanced contractile force, but elicited spontaneous contractions and impaired Ca2+ handling. Continuous exposure provoked an impairment of contractile force. In human atrial mitochondria from AF individuals, C18:1AC inhibited respiration. In a population-based cohort as well as a cohort of patients, high C18:1AC serum concentrations were associated with the incidence and prevalence of AF.Conclusion Our data provide evidence for an arrhythmogenic potential of the metabolite C18:1AC. The metabolite interferes with mitochondrial metabolism, thereby contributing to contractile dysfunction and shows predictive potential as novel circulating biomarker for risk of AF.

引用

页数：16

共 50 条

[41] Efficacy of isoproterenol in the evaluation of dormant conduction and arrhythmogenic foci identification in atrial fibrillation ablation
Sakamoto, Yusuke
Osanai, Hiroyuki
Hiramatsu, Shotaro
Matsumoto, Hikari
Tagahara, Kensuke
Hosono, Hirotaka
Miyamoto, Shun
Uno, Hiroto
Kurokawa, Hideki
Kondo, Shun
Tokuda, Kotaro
Kanbara, Takahiro
Nakashima, Yoshihito
Asano, Hiroshi
Ajioka, Masayoshi
BMC CARDIOVASCULAR DISORDERS, 2020, 20 (01)
[42] Atrial fibrillation: A developmental point of view
Mommersteeg, Mathilda T. M.
Christoffels, Vincent M.
Anderson, Robert H.
Moorman, Antoon F. M.
HEART RHYTHM, 2009, 6 (12) : 1818 - 1824
[43] Efficacy of isoproterenol in the evaluation of dormant conduction and arrhythmogenic foci identification in atrial fibrillation ablation
Yusuke Sakamoto
Hiroyuki Osanai
Shotaro Hiramatsu
Hikari Matsumoto
Kensuke Tagahara
Hirotaka Hosono
Shun Miyamoto
Hiroto Uno
Hideki Kurokawa
Shun Kondo
Kotaro Tokuda
Takahiro Kanbara
Yoshihito Nakashima
Hiroshi Asano
Masayoshi Ajioka
BMC Cardiovascular Disorders, 20
[44] Factors predicting an arrhythmogenic superior vena cava in atrial fibrillation ablation: Insight into the mechanism
Miyazaki, Shinsuke
Taniguchi, Hiroshi
Kusa, Shigeki
Ichihara, Noboru
Nakamura, Hiroaki
Hachiya, Hitoshi
Iesaka, Yoshito
HEART RHYTHM, 2014, 11 (09) : 1560 - 1566
[45] Atrial myocyte-derived exosomal microRNA contributes to atrial fibrosis in atrial fibrillation
Hao, Hongting
Yan, Sen
Zhao, Xinbo
Han, Xuejie
Fang, Ning
Zhang, Yun
Dai, Chenguang
Li, Wenpeng
Yu, Hui
Gao, Yunlong
Wang, Dingyu
Gao, Qiang
Duan, Yu
Yuan, Yue
Li, Yue
JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
[46] Arrhythmogenic substrate for atrial fibrillation: Insights from an integrative computational model of pulmonary veins
Aslanidi, Oleg V.
Colman, Michael A.
Zhao, Jichao
Smaill, Bruce H.
Gilbert, Stephen H.
Hancox, Jules C.
Boyett, Mark R.
Zhang, Henggui
2012 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 2012, : 203 - 206
[47] Left Atrial Voltage during Atrial Fibrillation in Paroxysmal and Persistent Atrial Fibrillation Patients
Fiala, Martin
Wichterle, Dan
Chovancik, Jan
Bulkova, Veronika
Wojnarova, Dorota
Nevralova, Renata
Januska, Jaroslav
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2010, 33 (05): : 541 - 548
[48] Proteomic Analysis of Atrial Appendages Revealed the Pathophysiological Changes of Atrial Fibrillation
Liu, Ban
Li, Xiang
Zhao, Cuimei
Wang, Yuliang
Lv, Mengwei
Shi, Xin
Han, Chunyan
Pandey, Pratik
Qian, Chunhua
Guo, Changfa
Zhang, Yangyang
FRONTIERS IN PHYSIOLOGY, 2020, 11
[49] PAGln, an Atrial Fibrillation-Linked Gut Microbial Metabolite, Acts as a Promoter of Atrial Myocyte Injury
Fang, Chen
Zuo, Kun
Jiao, Kaicheng
Zhu, Xiaoming
Fu, Yuan
Zhong, Jiuchang
Xu, Li
Yang, Xinchun
BIOMOLECULES, 2022, 12 (08)
[50] Therapeutic Prospects of Gene Therapy for Atrial Fibrillation
Farraha, Melad
Chong, James J. H.
Kizana, Eddy
HEART LUNG AND CIRCULATION, 2016, 25 (08) : 808 - 813

← 1 2 3 4 5 →